1. Erlotinib

   • Victoria J. Muir
   • Sohita Dhillon

   Adis Drug Profile 16 August 2012 Pages: 139 - 146

   

2. Activity and Safety of Dasatinib as Second-Line Treatment or in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

   • Massimo Breccia
   • Giuliana Alimena

   Review Article 16 August 2012 Pages: 147 - 157

   

3. Bevacizumab-Induced Hypertension

   • Kostas N. Syrigos
   • Eleni Karapanagiotou
   • Kevin Harrington

   Review Article 16 August 2012 Pages: 159 - 169

   

4. Neovascular Age-Related Macular Degeneration

   • Raymond M. Schiffelers
   • Tjitske K. van der Vaart
   • Gert Storm

   Review Article 16 August 2012 Pages: 171 - 189

   

5. Imatinib: As Adjuvant Therapy for Gastrointestinal Stromal Tumor

   • Mark Sanford
   • Lesley J. Scott

   Adis Profile Report 16 August 2012 Pages: 191 - 192

   

6. Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma

   • Sheridan M. Hoy
   • Kate McKeage

   Adis Profile Report 16 August 2012 Pages: 193 - 195

   

7. Hot Ortho-Biologic Topics at AAOS 2011

   • Julie Hoggatt

   InThought Alert 16 August 2012 Pages: 197 - 202

8. Belimumab Efficacy is ‘Mild’ but Market Potential Still Great

   • Ben Weintraub

   InThought Alert 16 August 2012 Pages: 203 - 205